Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SELL |
| Upstream (Parents) |
|---|
| (<<) PLEK → SELL |
| (<<) FCGR3B → SELL |
| (<<) EVI2B → SELL |
| (<<) PTPRC → SELL |
| (<<) MNDA → SELL |
| Downstream (Children) |
|---|
| SELL → APOBEC3A (>>) |
| SELL → VNN2 (>>) |
| SELL → FFAR2 (>>) |
| SELL → LOC642103///MGAM (>>) |
| SELL → S100A12 (>>) |
| SELL → ZAP70 (>>) |
| SELL → MS4A1 (>>) |
| SELL → FAM65B (>>) |
| SELL → KCNA3 (>>) |
| SELL → IL18RAP (>>) |
| SELL → FCN1 (>>) |
| SELL → FCGR3B (>>) |
| SELL → ZNF74 (>>) |
| SELL → RGS2 (>>) |
| SELL → CXCR2 (>>) |
| SELL → PQLC3 (>>) |
